Melatonin suppresses tumor proliferation and metastasis by targeting GATA2 in endometrial cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin suppresses tumor proliferation and metastasis by targeting GATA2 in endometrial cancer
Authors
Keywords
-
Journal
JOURNAL OF PINEAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-12
DOI
10.1111/jpi.12918
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LINC00891 regulated by miR-128-3p/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway
- (2022) Yunfeng Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer
- (2022) Quan Zhou et al. Journal of Ovarian Research
- A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X
- (2022) Yuliang Pan et al. Journal of Translational Medicine
- MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
- (2021) Tao Shen et al. JOURNAL OF CLINICAL INVESTIGATION
- Melatonin and Cancer: A Polyhedral Network Where the Source Matters
- (2021) Maria-Angeles Bonmati-Carrion et al. Antioxidants
- Melatonin and its mechanism of action in the female reproductive system and related malignancies
- (2021) Maryam Ezzati et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
- (2021) Wamidh H. Talib et al. MOLECULES
- Melatonin alleviates progression of uterine endometrial cancer by suppressing estrogen/ubiquitin C/SDHB-mediated succinate accumulation
- (2020) Chunjie Gu et al. CANCER LETTERS
- Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b
- (2020) Wei Wang et al. Cancer Cell International
- Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics
- (2020) Bo Chen et al. INVESTIGATIONAL NEW DRUGS
- Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis
- (2020) Huishan Zhao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE/AKT/β-catenin/SLUG axis
- (2020) Shixia Bu et al. Cell Death & Disease
- Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
- (2019) Jiaojiao Hao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis
- (2019) Lotfolah Saed et al. BMC CANCER
- The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer
- (2019) Franziska Büscheck et al. TUMOR BIOLOGY
- Molecular and biological functions of melatonin in endometrial cancer
- (2019) Parisa Maleki Dana et al. CURRENT DRUG TARGETS
- The melatonin-MT1 receptor axis modulates tumor growth in PTEN -mutated gliomas
- (2018) Huihui Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mitochondrial functions and melatonin: a tour of the reproductive cancers
- (2018) Luiz Gustavo de Almeida Chuffa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- GATA transcription factors in development and disease
- (2018) Mathieu Tremblay et al. DEVELOPMENT
- Melanoma in patients with GATA2 deficiency
- (2017) Jannett Nguyen et al. Pigment Cell & Melanoma Research
- Melatonin for the prevention and treatment of cancer
- (2017) Ya Li et al. Oncotarget
- MT1and MT2Melatonin Receptors: A Therapeutic Perspective
- (2016) Jiabei Liu et al. Annual Review of Pharmacology and Toxicology
- The role of GATA2 in lethal prostate cancer aggressiveness
- (2016) Veronica Rodriguez-Bravo et al. Nature Reviews Urology
- GATA3 immunohistochemical expression in invasive urothelial carcinoma
- (2016) Kareem Hosny Mohammed et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Haematopoietic and immune defects associated withGATA2mutation
- (2015) Matthew Collin et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
- (2015) Samuel J. Vidal et al. CANCER CELL
- Melatonin: an inhibitor of breast cancer
- (2015) S. M. Hill et al. ENDOCRINE-RELATED CANCER
- GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway
- (2015) Zhongyong Wang et al. MEDICAL ONCOLOGY
- GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer
- (2015) Xijuan Liu et al. PLoS One
- Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
- (2014) Yi-Wei Li et al. PLoS One
- Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
- (2014) Inga Peters et al. Targeted Oncology
- Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats
- (2014) Grazielle M. Ferreira et al. Journal of Cancer
- Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer
- (2013) Lei Chen et al. MEDICAL ONCOLOGY
- Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation
- (2012) Emilio J Sanchez-Barcelo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Melatonin signaling and cell protection function
- (2010) Francesca Luchetti et al. FASEB JOURNAL
- GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes
- (2009) V Hoene et al. BRITISH JOURNAL OF CANCER
- Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma
- (2008) Erina Nakamura et al. CANCER SCIENCE
- Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line
- (2008) Mari Watanabe et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search